GILD
Gilead Sciences Inc. Common Stock
$112.050+-0.000 (-0.000%)
Echtzeitkurs
Kursdiagramm
Loading Chart...
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$112.050
Hoch
$112.050
Tief
$112.050
Volumen
6.41M
Unternehmensfundamentaldaten
Handelsstatistiken
Ähnliche Nachrichten
Reuters
US FDA places clinical hold on Gilead trials testing HIV pill combination
The U.S. Food and Drug Administration has placed a clinical hold on Gilead Sciences' trials testing a combination of two of its experimental HIV treatments, the company said on Tuesday.
Mehr anzeigen
CNBC
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, Medicare patients.
Mehr anzeigen
BusinessWire
ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors
– Second Positive Phase 3 Trial in First-line Metastatic TNBC Where Trodelvy Has Demonstrated a Clinically Meaningful Benefit Versus Standard of Care Chemotherapy – – Trodelvy Has the Potential to Be the Backbone of
Mehr anzeigen
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.